Agentix (AGTX) Price & Analysis

11 Followers

AGTX Stock Chart & Stats

$0.02

$0.00(0.00%)

At close: Jun 30 4:00 PM EDT

$0.02

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.06

Previous CloseN/A

Volume1.00

Average Volume (3M)15.94K

Market Cap

$801.34K

Enterprise Value$674.74K

Total Cash (Recent Filing)$771.00

Total Debt (Recent Filing)$353.45K

Price to Earnings (P/E)―

Beta1.13

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding40,066,950

10 Day Avg. Volume5,559

30 Day Avg. Volume15,942

Financial Highlights & Ratios

PEG Ratio0.14

Price to Book (P/B)-0.47

Price to Sales (P/S)0.00

P/FCF Ratio-15.51

Enterprise Value/Market Cap0.84

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-1.52

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

AGTX FAQ

What was Agentix Corp.’s price range in the past 12 months?

Agentix Corp. lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.

What is Agentix Corp.’s market cap?

Agentix Corp.’s market cap is $801.34K.

When is Agentix Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Agentix Corp.’s earnings last quarter?

Currently, no data Available

Is Agentix Corp. overvalued?

According to Wall Street analysts Agentix Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Agentix Corp. pay dividends?

Agentix Corp. does not currently pay dividends.

What is Agentix Corp.’s EPS estimate?

Agentix Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Agentix Corp. have?

Agentix Corp. has 40,066,950 shares outstanding.

What happened to Agentix Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Agentix Corp.?

Currently, no hedge funds are holding shares in AGTX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Agentix Corp.

Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.